Litika Vermani

Dr. Litika Vermani


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DKDavid Kudrén
David Kudrén
LWLinda Waage
Linda Waage
JWJohanna Samola Winnberg
Johanna Samola Winnberg
MLMats Lindblad
Mats Lindblad
CLChunde Li
Chunde Li
LVLitika Vermani
Litika Vermani
Previous haplotype Genome Wide Association Studies (GWASs) have suggested several rare loci with a shared increased risk of colorectal, gastric, and prostate cancer. This study aimed to find out more about markers specifically addressing the shared risk of colorectal and gastric cancer, as well as the shared risk of colorectal and prostate cancer. One analysis used 426 colorectal cancer cases with gastric cancer, with no prostate cancer cases in their families, and another analysis used 324 colorectal cancer cases with prostate cancer but no gastric cancer among relatives. The computational program PLINK v1.07 was used for the analysis and for the calculation of corresponding ORs, standard errors, and 95% confidence intervals (CI). The study found support for the loci from previous studies and many new loci with a shared risk of colorectal cancer and gastric cancer. There were no significant loci from the second analysis for a shared risk of colorectal and prostate cancer. Altogether, more than 100 new loci with a shared risk of colorectal cancer and gastric cancer were suggested. A shared risk of colorectal and prostate cancer at some loci could not be ruled out. Haplotype GWAS has again demonstrated its ability to find rare risk loci mostly associated with coding genes.

Verified
Journal Article
Open access
PDF file
LVLitika Vermani
Litika Vermani
SBShabane Barot
Shabane Barot
ALAnnika Lindblom
Annika Lindblom
Genetic variants specific to anatomical subsites of colorectal cancer are known to play a crucial role in its prognosis and treatment. We undertook a haplotype-based genome-wide association study (GWAS) to identify specific genetic risk loci for three sites: cecum, right colorectum, and left colorectum. Six different haplotype GWAS were performed using familial and sporadic colorectal cancer cases with tumors at three different sites. The studies included 2358 CRC cases and 1642 healthy controls. A logistic regression model using PLINK v.1.07 software was employed, and risk loci with a p-value of 5 × 10−8 were considered statistically significant. In total, 29 distinct risk loci were identified in the analyses of familial and sporadic cases of cecal and proximal colon cancer. The results from the analyses of familial and sporadic left-sided colorectal cancer did not meet the strict criteria for significance. Among the loci that were associated with cecal cancer, 14 were familial, and seven were sporadic. Among the other right-sided colon cancer loci, six were familial, and two were sporadic. Coding genes were found at 18 of the 29 loci. Our findings of site-specific genetic risk loci support the growing evidence for divergent pathways in familial and sporadic colorectal cancer across different colorectal sites. The data support a model where the rise in proximal tumors, both familial and sporadic, is influenced by genetic risk to a higher degree than that of distal tumors. These findings are important for understanding colorectal carcinogenesis and could, after future studies, lead to new applications in cancer prevention, treatment, and prognosis.

10 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
MIMayuri Iyer
Mayuri Iyer
TBTamanna Bhuyan
Tamanna Bhuyan
LVLitika Vermani
Litika Vermani
MDMonalisa Deka
Monalisa Deka
SRSanthoshkumar Rajendran
Santhoshkumar Rajendran
RKRajeev Kumar
Rajeev Kumar
Background: Reliability of differential gene expression analysis in cancer studies depends on the selection of normalising reference genes. The current study aimed to identify and validate suitable reference genes for the normalization of quantitative real-time polymerase chain reaction (qPCR)-based differential gene expression analysis of cancer stem cells (CSC) and epithelial-to-mesenchymal transition (EMT) markers in breast cancer tissue. Methodology: The expression stability of six candidate reference genes— PUM1, RPN1, GUSB, PMM1, GAPDH, and B2M —across 18 breast cancer specimens was assessed using qPCR method. Gene stability was analysed using RefFinder algorithm. Further, the suitability of the optimum reference genes was assessed using qPCR-based differential gene expression analysis of CSC and EMT markers, namely ALDH1 , VIM , TWIST , and CDH1 , in a cohort of breast cancer tissues constituting the four intrinsic molecular subgroups– Luminal A, Luminal B, Triple Negative Breast Cancer (TNBC), and HER 2-Enriched. Results: The geometric mean of C q values for PUM1, RPN1, GUSB, PMM, B2M, and GAPDH were found 19.95, 18.26, 21.12, 22.10, 14.64, and 16.0, respectively. ReFfinder provided a comprehensive assessment of gene stability, ranking the candidate reference genes in the following order of decreasing stability: PUM1 (1.0), RPN1 (1.86), GUSB (3.41), PMM (4.0), B2M (4.56), and GAPDH (5.23). PUM1 and RPN1 were observed as the most stably expressed reference genes whereas GAPDH was most unstably expressed across all the breast cancer tissues. Using PUM1 and RPN1 as reference genes, the following gene expression patterns were observed: ALDH1 showed the lowest expression in Luminal B; TWIST and VIM expressions peaked in HER 2-Enriched subtype, with VIM being expressed the lowest in Luminal B; CDH1 expression was lowest in HER 2-Enriched and highest in Luminal B. Conclusion: In our cohort PUM1 and RPN1 reference genes were found to be most stable and were suitable for the normalization of qPCR-based gene expression of CSC and EMT markers. However, these findings need to be validated on a larger cohort.

19 November 2026 in Genes
Verified
Journal Article
Open access
PDF file
EBElin Barnekow
Elin Barnekow
LVLitika Vermani
Litika Vermani
WLWen Liu
Wen Liu
CWCamilla Wendt
Camilla Wendt
SMSara Margolin
Sara Margolin
ALAnnika Lindblom
Annika Lindblom
Introduction: The current concept of complex disease is that genes and environmental or lifestyle factors interact to increase the risk of disease. In our previous GWAS studies, we unexpectedly observed one new risk haplotype in a cohort of sporadic breast cancer cases associated with a higher risk than in a cohort of familial breast cancer cases. We set out to find support for a hypothesis on a different model of susceptibility genes in complex disease than the currently assumed one. Methods: A logistic regression model using PLINK v.1.07 software was employed in the previous studies. Data from the three previous genome-wide association analyses using familial and sporadic breast cancer cases were reanalyzed. Here, we looked at haplotypes where data were available for all three studies. Odds ratios were used as a proxy for risk. Results: Two patterns of inheritance were seen. In the first pattern, and current concept, haplotypes showed the highest odds ratios in familial samples and the lowest in sporadic samples. In the second pattern, haplotypes exhibited the highest odds ratio in sporadic samples and the lowest in familial samples. One possible explanation was that genes at those loci differ in their modifying effects. Conclusions: Familial breast cancer may be associated with genes that have stronger direct genetic effects and weaker modifying effects, whereas the opposite applies to sporadic breast cancer. Our findings suggest a new model for breast cancer as a complex disease and call for future studies to test this hypothesis. The findings are relevant in breast carcinogenesis and cancer prevention.